Ohkawa T - Search Results

1

Kijima H, Ishida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Kijima H, et al. Among authors: ohkawa t. Pharmacol Ther. 1995;68(2):247-67. doi: 10.1016/0163-7258(95)02008-x. Pharmacol Ther. 1995. PMID: 8719970 Review.

2

Oligonucleotide-mediated modulation of mammalian gene expression.

Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G, Kashani-Sabet M. Scanlon KJ, et al. Among authors: ohkawa t. FASEB J. 1995 Oct;9(13):1288-96. doi: 10.1096/fasebj.9.13.7557018. FASEB J. 1995. PMID: 7557018 Review.

3

Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells.

Ohta Y, Kijima H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Ohta Y, et al. Among authors: ohkawa t. Nucleic Acids Res. 1996 Mar 1;24(5):938-42. doi: 10.1093/nar/24.5.938. Nucleic Acids Res. 1996. PMID: 8600463 Free PMC article.

4

Anti-oncogene ribozymes for cancer gene therapy.

Irie A, Kijima H, Ohkawa T, Bouffard DY, Suzuki T, Curcio LD, Holm PS, Sassani A, Scanlon KJ. Irie A, et al. Among authors: ohkawa t. Adv Pharmacol. 1997;40:207-57. doi: 10.1016/s1054-3589(08)60141-6. Adv Pharmacol. 1997. PMID: 9217927 Review. No abstract available.

5

Oligonucleotide modulation of multidrug resistance.

Bouffard DY, Ohkawa T, Kijima H, Irie A, Suzuki T, Curcio LD, Holm PS, Sassani A, Scanlon KJ. Bouffard DY, et al. Among authors: ohkawa t. Eur J Cancer. 1996 Jun;32A(6):1010-8. doi: 10.1016/0959-8049(96)00065-2. Eur J Cancer. 1996. PMID: 8763342 Review. No abstract available.

6

Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer.

Irie A, Anderegg B, Kashani-Sabet M, Ohkawa T, Suzuki T, Halks-Miller M, Curiel DT, Scanlon KJ. Irie A, et al. Among authors: ohkawa t. Antisense Nucleic Acid Drug Dev. 1999 Aug;9(4):341-9. doi: 10.1089/oli.1.1999.9.341. Antisense Nucleic Acid Drug Dev. 1999. PMID: 10463078

7

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.

Suzuki T, Anderegg B, Ohkawa T, Irie A, Engebraaten O, Halks-Miller M, Holm PS, Curiel DT, Kashani-Sabet M, Scanlon KJ. Suzuki T, et al. Among authors: ohkawa t. Gene Ther. 2000 Feb;7(3):241-8. doi: 10.1038/sj.gt.3301065. Gene Ther. 2000. PMID: 10694801

8

Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.

Uno F, Fujiwara T, Takata Y, Ohtani S, Katsuda K, Takaoka M, Ohkawa T, Naomoto Y, Nakajima M, Tanaka N. Uno F, et al. Among authors: ohkawa t. Cancer Res. 2001 Nov 1;61(21):7855-60. Cancer Res. 2001. PMID: 11691803

9

Heparanase expression correlates with malignant potential in human colon cancer.

Nobuhisa T, Naomoto Y, Ohkawa T, Takaoka M, Ono R, Murata T, Gunduz M, Shirakawa Y, Yamatsuji T, Haisa M, Matsuoka J, Tsujigiwa H, Nagatsuka H, Nakajima M, Tanaka N. Nobuhisa T, et al. Among authors: ohkawa t. J Cancer Res Clin Oncol. 2005 Apr;131(4):229-37. doi: 10.1007/s00432-004-0644-x. Epub 2004 Dec 30. J Cancer Res Clin Oncol. 2005. PMID: 15625607

10

Heparanase expression correlates with invasion and poor prognosis in gastric cancers.

Takaoka M, Naomoto Y, Ohkawa T, Uetsuka H, Shirakawa Y, Uno F, Fujiwara T, Gunduz M, Nagatsuka H, Nakajima M, Tanaka N, Haisa M. Takaoka M, et al. Among authors: ohkawa t. Lab Invest. 2003 May;83(5):613-22. doi: 10.1097/01.lab.0000067482.84946.bd. Lab Invest. 2003. PMID: 12746471 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters